CARBOPLATIN and DYSPNOEA

Overview

DYSPNOEA is the #10 most commonly reported adverse reaction for CARBOPLATIN, manufactured by Accord Healthcare, Inc.. There are 5,212 FDA adverse event reports linking CARBOPLATIN to DYSPNOEA. This represents approximately 2.4% of all 214,224 adverse event reports for this drug.

Patients taking CARBOPLATIN who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for CARBOPLATIN, but still significant enough to appear in the safety profile.

Other Side Effects of CARBOPLATIN

In addition to dyspnoea, the following adverse reactions have been reported for CARBOPLATIN:

• OFF LABEL USE — 8,005 reports
• NEUTROPENIA — 7,120 reports
• ANAEMIA — 6,913 reports
• NAUSEA — 6,797 reports
• FEBRILE NEUTROPENIA — 6,305 reports
• DIARRHOEA — 5,943 reports
• DISEASE PROGRESSION — 5,838 reports
• MALIGNANT NEOPLASM PROGRESSION — 5,707 reports
• THROMBOCYTOPENIA — 5,671 reports
• VOMITING — 4,982 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does CARBOPLATIN cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 5,212 FDA reports for CARBOPLATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with CARBOPLATIN?

DYSPNOEA accounts for approximately 2.4% of all adverse event reports for CARBOPLATIN, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking CARBOPLATIN?

If you experience dyspnoea while taking CARBOPLATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages